vs

Side-by-side financial comparison of Mawson Infrastructure Group Inc. (MIGI) and Vivos Therapeutics, Inc. (VVOS). Click either name above to swap in a different company.

Vivos Therapeutics, Inc. is the larger business by last-quarter revenue ($3.8M vs $3.2M, roughly 1.2× Mawson Infrastructure Group Inc.). On growth, Vivos Therapeutics, Inc. posted the faster year-over-year revenue change (3.4% vs -78.5%). Vivos Therapeutics, Inc. produced more free cash flow last quarter ($-5.3M vs $-7.0M). Over the past eight quarters, Vivos Therapeutics, Inc.'s revenue compounded faster (5.8% CAGR vs -58.5%).

Mawson Infrastructure Group Inc. is a global digital infrastructure provider that operates sustainable, energy-efficient data centers and specialized hosting solutions for blockchain and digital asset operations. Its core segments include cryptocurrency mining, colocation services, and low-carbon infrastructure development, with primary operational footprints across North America and Australia.

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

MIGI vs VVOS — Head-to-Head

Bigger by revenue
VVOS
VVOS
1.2× larger
VVOS
$3.8M
$3.2M
MIGI
Growing faster (revenue YoY)
VVOS
VVOS
+82.0% gap
VVOS
3.4%
-78.5%
MIGI
More free cash flow
VVOS
VVOS
$1.7M more FCF
VVOS
$-5.3M
$-7.0M
MIGI
Faster 2-yr revenue CAGR
VVOS
VVOS
Annualised
VVOS
5.8%
-58.5%
MIGI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MIGI
MIGI
VVOS
VVOS
Revenue
$3.2M
$3.8M
Net Profit
$-6.9M
Gross Margin
78.1%
Operating Margin
-166.8%
Net Margin
-180.3%
Revenue YoY
-78.5%
3.4%
Net Profit YoY
-246.2%
-143.8%
EPS (diluted)
$-0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MIGI
MIGI
VVOS
VVOS
Q4 25
$3.2M
$3.8M
Q3 25
$13.2M
$6.8M
Q2 25
$9.5M
$3.8M
Q1 25
$13.8M
$3.0M
Q4 24
$15.1M
$3.7M
Q3 24
$12.3M
$3.9M
Q2 24
$13.1M
$4.1M
Q1 24
$18.8M
$3.4M
Net Profit
MIGI
MIGI
VVOS
VVOS
Q4 25
$-6.9M
Q3 25
$327.7K
$-5.4M
Q2 25
$-8.0M
$-5.0M
Q1 25
$-310.9K
$-3.9M
Q4 24
$-4.5M
$-2.8M
Q3 24
$-12.2M
$-2.6M
Q2 24
$-9.6M
$-1.9M
Q1 24
$-19.8M
$-3.8M
Gross Margin
MIGI
MIGI
VVOS
VVOS
Q4 25
78.1%
Q3 25
65.0%
58.0%
Q2 25
41.3%
55.2%
Q1 25
42.9%
50.0%
Q4 24
30.9%
56.7%
Q3 24
35.1%
60.5%
Q2 24
32.9%
65.4%
Q1 24
37.2%
56.7%
Operating Margin
MIGI
MIGI
VVOS
VVOS
Q4 25
-166.8%
Q3 25
12.0%
-69.8%
Q2 25
-68.9%
-127.4%
Q1 25
4.2%
-129.9%
Q4 24
-35.2%
-75.9%
Q3 24
-92.6%
-68.5%
Q2 24
-51.5%
-47.8%
Q1 24
-41.0%
-110.7%
Net Margin
MIGI
MIGI
VVOS
VVOS
Q4 25
-180.3%
Q3 25
2.5%
-79.6%
Q2 25
-84.1%
-131.2%
Q1 25
-2.3%
-128.1%
Q4 24
-30.0%
-76.4%
Q3 24
-99.3%
-67.8%
Q2 24
-73.4%
-47.6%
Q1 24
-105.3%
-110.1%
EPS (diluted)
MIGI
MIGI
VVOS
VVOS
Q4 25
$-0.58
Q3 25
$0.01
$-0.49
Q2 25
$-0.40
$-0.55
Q1 25
$-0.02
$-0.45
Q4 24
$-49.35
$0.41
Q3 24
$-0.66
$-0.40
Q2 24
$-0.55
$-0.60
Q1 24
$-1.19
$-1.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MIGI
MIGI
VVOS
VVOS
Cash + ST InvestmentsLiquidity on hand
$13.3M
$2.0M
Total DebtLower is stronger
$25.2M
$2.9M
Stockholders' EquityBook value
$-3.1M
$-1.5M
Total Assets
$57.4M
$25.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MIGI
MIGI
VVOS
VVOS
Q4 25
$13.3M
$2.0M
Q3 25
$2.3M
$3.1M
Q2 25
$3.2M
$4.4M
Q1 25
$5.5M
$2.3M
Q4 24
$6.1M
$6.3M
Q3 24
$5.8M
$6.3M
Q2 24
$6.8M
$6.9M
Q1 24
$6.4M
$2.6M
Total Debt
MIGI
MIGI
VVOS
VVOS
Q4 25
$25.2M
$2.9M
Q3 25
Q2 25
Q1 25
Q4 24
$20.9M
$1.2M
Q3 24
$1.2M
Q2 24
$393.2K
$1.2M
Q1 24
$41.5K
Stockholders' Equity
MIGI
MIGI
VVOS
VVOS
Q4 25
$-3.1M
$-1.5M
Q3 25
$-9.4M
$2.5M
Q2 25
$-8.3M
$4.6M
Q1 25
$-1.4M
$4.4M
Q4 24
$-3.2M
$8.0M
Q3 24
$-1.6M
$7.7M
Q2 24
$4.4M
$6.3M
Q1 24
$13.0M
$582.0K
Total Assets
MIGI
MIGI
VVOS
VVOS
Q4 25
$57.4M
$25.2M
Q3 25
$52.0M
$25.6M
Q2 25
$52.7M
$26.0M
Q1 25
$57.9M
$11.3M
Q4 24
$61.4M
$15.3M
Q3 24
$60.8M
$15.3M
Q2 24
$65.6M
$15.8M
Q1 24
$67.7M
$11.8M
Debt / Equity
MIGI
MIGI
VVOS
VVOS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
0.16×
Q2 24
0.09×
0.19×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MIGI
MIGI
VVOS
VVOS
Operating Cash FlowLast quarter
$-6.9M
$-3.8M
Free Cash FlowOCF − Capex
$-7.0M
$-5.3M
FCF MarginFCF / Revenue
-218.1%
-139.7%
Capex IntensityCapex / Revenue
4.6%
40.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-10.6M
$-17.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MIGI
MIGI
VVOS
VVOS
Q4 25
$-6.9M
$-3.8M
Q3 25
$-844.5K
$-4.2M
Q2 25
$-2.1M
$-3.5M
Q1 25
$-510.4K
$-3.8M
Q4 24
$3.6M
$-2.9M
Q3 24
$-1.2M
$-4.2M
Q2 24
$2.5M
$-3.0M
Q1 24
$1.9M
$-2.5M
Free Cash Flow
MIGI
MIGI
VVOS
VVOS
Q4 25
$-7.0M
$-5.3M
Q3 25
$-859.7K
$-4.2M
Q2 25
$-2.1M
$-4.3M
Q1 25
$-516.9K
$-3.9M
Q4 24
$1.6M
$-3.1M
Q3 24
$-1.3M
$-4.4M
Q2 24
$592.4K
$-3.1M
Q1 24
$1.9M
$-2.7M
FCF Margin
MIGI
MIGI
VVOS
VVOS
Q4 25
-218.1%
-139.7%
Q3 25
-6.5%
-62.6%
Q2 25
-22.3%
-111.6%
Q1 25
-3.7%
-129.9%
Q4 24
10.7%
-84.0%
Q3 24
-10.4%
-113.4%
Q2 24
4.5%
-76.7%
Q1 24
9.9%
-78.0%
Capex Intensity
MIGI
MIGI
VVOS
VVOS
Q4 25
4.6%
40.0%
Q3 25
0.1%
1.2%
Q2 25
0.5%
20.2%
Q1 25
0.0%
4.0%
Q4 24
13.0%
4.5%
Q3 24
0.3%
5.0%
Q2 24
14.3%
1.5%
Q1 24
0.1%
4.4%
Cash Conversion
MIGI
MIGI
VVOS
VVOS
Q4 25
Q3 25
-2.58×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MIGI
MIGI

Segment breakdown not available.

VVOS
VVOS

Services$3.2M84%
Products$594.0K16%

Related Comparisons